Literature DB >> 15048077

Genomic DNA is captured and amplified during double-strand break (DSB) repair in human cells.

Kevin C E Little1, Pierre Chartrand.   

Abstract

Genomic stability is maintained by the surveillance and repair of DNA damage. Here, we describe a mechanism whereby repair of extrachromosomal DNA double-strand breaks (DSBs) in human cells can be accompanied by capture of genomic DNA fragments. The availability of the human genome sequence enabled us to characterize these inserts in cells from a normal individual and from a patient with ataxia telangiectasia (AT), deficient for the damage response kinase ATM and prone to genomic instability. We find AT cells exhibit insertions of human chromosomal DNA fragments in excess of 17 kb during DSB repair, whereas we detected no such genomic inserts in normal cells. However, the presence of simian virus 40 (SV40), used to transform these cell lines, resulted in capture of genomic DNA associated with sites of viral integration in both cell types. The genomic instability at sites of SV40 integration was exported to other sites of DNA damage, and acquisition of the viral origin of replication resulted in gene amplification through autonomous replication of the plasmid harbouring the repaired extrachromosomal DSB. Should this same phenomenon apply to the repair of chromosomal DSBs, genome rearrangements made possible via this DSB insertional repair pose risks to genomic integrity, and may contribute to tumorigenic progression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15048077     DOI: 10.1038/sj.onc.1207570

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  8 in total

1.  Architectures of somatic genomic rearrangement in human cancer amplicons at sequence-level resolution.

Authors:  Graham R Bignell; Thomas Santarius; Jessica C M Pole; Adam P Butler; Janet Perry; Erin Pleasance; Chris Greenman; Andrew Menzies; Sheila Taylor; Sarah Edkins; Peter Campbell; Michael Quail; Bob Plumb; Lucy Matthews; Kirsten McLay; Paul A W Edwards; Jane Rogers; Richard Wooster; P Andrew Futreal; Michael R Stratton
Journal:  Genome Res       Date:  2007-08-03       Impact factor: 9.043

2.  Autophagy suppresses tumor progression by limiting chromosomal instability.

Authors:  Robin Mathew; Sameera Kongara; Brian Beaudoin; Cristina M Karp; Kevin Bray; Kurt Degenhardt; Guanghua Chen; Shengkan Jin; Eileen White
Journal:  Genes Dev       Date:  2007-05-17       Impact factor: 11.361

3.  Assessing metabolic stress and autophagy status in epithelial tumors.

Authors:  Robin Mathew; Vassiliki Karantza-Wadsworth; Eileen White
Journal:  Methods Enzymol       Date:  2009       Impact factor: 1.600

4.  Capture of extranuclear DNA at fission yeast double-strand breaks.

Authors:  Anabelle Decottignies
Journal:  Genetics       Date:  2005-09-02       Impact factor: 4.562

5.  UV radiation induces delayed hyperrecombination associated with hypermutation in human cells.

Authors:  Stephen T Durant; Kimberly S Paffett; Meena Shrivastav; Graham S Timmins; William F Morgan; Jac A Nickoloff
Journal:  Mol Cell Biol       Date:  2006-08       Impact factor: 4.272

6.  The value of multi-modal gene screening in HNPCC in Quebec: three mutations in mismatch repair genes that would have not been correctly identified by genomic DNA sequencing alone.

Authors:  Susan McVety; Lili Li; Isabelle Thiffault; Philip H Gordon; Elizabeth Macnamara; Nora Wong; Karlene Australie; Lidia Kasprzak; George Chong; William D Foulkes
Journal:  Fam Cancer       Date:  2006       Impact factor: 2.375

7.  Non-homologous end joining repair mechanism-mediated deletion of CHD7 gene in a patient with typical CHARGE syndrome.

Authors:  Seung Jun Lee; Jong Hee Chae; Jung Ae Lee; Sung Im Cho; Soo Hyun Seo; Hyunwoong Park; Moon-Woo Seong; Sung Sup Park
Journal:  Ann Lab Med       Date:  2014-12-08       Impact factor: 3.464

8.  Partial PTEN deletion is linked to poor prognosis in breast cancer.

Authors:  P Lebok; V Kopperschmidt; M Kluth; C Hube-Magg; C Özden; Taskin B; K Hussein; A Mittenzwei; A Lebeau; I Witzel; L Wölber; S Mahner; F Jänicke; S Geist; P Paluchowski; C Wilke; U Heilenkötter; Ronald Simon; Guido Sauter; L Terracciano; R Krech; A von d Assen; V Müller; E Burandt
Journal:  BMC Cancer       Date:  2015-12-16       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.